Achieve Life Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACHV | CADL | ZVRA | GENB | CTNM | AVBP | |
|---|---|---|---|---|---|---|
| Market cap | 727.90M | 748.35M | 672.22M | 1.78B | 322.22M | 811.61M |
| P/E (TTM) | — | — | 12.3 | — | — | — |
| Forward P/E | -10.8 | -15.6 | 10.5 | -6.1 | -4.5 | -4.2 |
| Price/book | -49.4 | 5.9 | 3.1 | 3.9 | 1.3 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +127.74% | +53.63% | +6.55% | +13.36% | +12.15% | −17.70% |
| Today | −4.72% | −1.61% | −0.61% | −3.49% | −35.99% | −1.61% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACHV news ›Mphasis Grants New ESOP and RSU Awards to Bolster Talent Retention
Mphasis Limited ( (IN:MPHASIS) ) just unveiled an announcement. Mphasis Limited has approved a new grant of employee equity incentives under its existing share-based compensation schemes. The move underscores the company’s continued…
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
“The discipline that determines how a launch goes is put in place long before the first prescription is written,” said Mr. Halladay. “That is the work I’m excited to do. Achieve is developing a medicine that could change what quitting…
Achieve Life Sciences initiated with a Buy at Stifel
Stifel initiated coverage of Achieve Life Sciences (ACHV) with a Buy rating and $18 price target After “an important transformation” that incl... Achieve Life Sciences initiated with a Buy at Stifel Stifel initiated coverage of Achieve…
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ... Achieve Life Sciences Announced…
Concept Life Sciences appoints new chief executive
Concept Life Sciences has appointed Dr Adrijana Vinter as chief executive, bringing more than two decades of experience in drug discovery, commercial development and leadership across the pharmaceutical and contract research sectors.…
UK: Concept Life Sciences appoints Adrijana Vinter as CEO
Concept Life Sciences (CLS), a UK-based CRO specialising in integrated drug discovery, development and analytical services, has appointed Dr Adrijana Vinter as CEO. Previously, Vinter held CEO and chief commercial officer roles at Fidelta,…
Concept Life Sciences Appoints Dr Adrijana Vinter as Chief Executive Officer
Experienced CRO leader brings deep scientific, commercial and operational expertise to lead the company’s next phase of growth Previously, Dr Vinter held Chief Executive Officer and Chief Commercial Officer roles at Fidelta, becoming CEO…
Harmony Biosciences appoints Peter Anastasiou as CEO
Harmony Biosciences HRMY announced Monday Peter Anastasiou has been appointed president, chief executive officer, and member of the Board of Directors, effective January 1, 2027. The firm highlighted that he succeeds Jeffrey Dayno, who…
Achieve Life Sciences Names Benjamin Halladay CFO
Achieve Life Sciences said Thursday it has named Benjamin Halladay its chief financial officer, effective Oct. 5. Halladay, who will succeed Mark Oki, was previously Esperion Therapeutics' CFO,... Achieve Life Sciences, Inc. Biotechnology…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com12
-
markets.businessinsider.com6
-
stocktitan.net6
-
tradingview.com3
-
gurufocus.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 40 articles, not a forecast.